Onder_2020_Arch.Biochem.Biophys__108728

In the present study, the inhibitory mechanisms and effects of a synthetic phenazine dye, safranin O (SO) on human plasma butyrylcholinesterase (BChE), human erythrocyte acetylcholinesterase (AChE) and recombinant BChE mutants were investigated. Kinetic studies showed the following information: SO leaded to linear competitive inhibition of human plasma BChE with K(i) = 0.44 +/- 0.085 M; alpha = . It acted as a hyperbolic noncompetitive inhibitor of human erythrocyte AChE with K(i) = 0.69 +/- 0.13; alpha = 1; beta = 0.08 +/- 0.02. On the other hand, the inhibitory effects of SO on two BChE mutants, where A328 was modified to either F or Y, revealed differences in terms of inhibitory patterns and K(i) values, compared to the obtained results with recombinant wild type BChE. SO was found to act as linear competitive inhibitors of A328F and A328Y BChE mutants. Compared to recombinant wild type BChE, A328Y and A328F BChE mutants caused a 4- and 10-fold decrease in K(i) value for SO, respectively. These findings were supported by molecular modelling studies. In conclusion, SO is a potent inhibitor of human cholinesterases and may be useful in the design and development of new drugs for the treatment of AD.